Cargando…

A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux

INTRODUCTION: The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortsäter, Gustaf, Borgström, Fredrik, Soulard, Stéphane, Miltenburger, Carolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860470/
https://www.ncbi.nlm.nih.gov/pubmed/31625130
http://dx.doi.org/10.1007/s12325-019-01114-1
_version_ 1783471246309064704
author Ortsäter, Gustaf
Borgström, Fredrik
Soulard, Stéphane
Miltenburger, Carolin
author_facet Ortsäter, Gustaf
Borgström, Fredrik
Soulard, Stéphane
Miltenburger, Carolin
author_sort Ortsäter, Gustaf
collection PubMed
description INTRODUCTION: The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies and inclusion of ecological considerations in the decision-making process for purchasing and funding of healthcare technologies. The objective of this study was to perform budget impact analysis of adopting RESPIMAT re-usable in the Nordics and Benelux that considered both the traditional healthcare costs as well as the environmental impact. METHODS: Inhaler costs and environmental impact over 5 years in the Nordics and Benelux in a scenario with RESPIMAT re-usable compared to a scenario without RESPIMAT re-usable were estimated using an budget impact model. RESPIMAT re-usable enables patients to re-use the inhaler device and its availability therefore reduces the number of inhalers and associated wastage. The carbon emissions were derived for each treatment pattern considering the whole life cycle (cradle-to-grave) of the inhaler product. The cost of carbon emissions was estimated using a societal cost per ton of carbon emission. RESULTS: Progressively introducing RESPIMAT re-usable in the Nordics and Benelux was estimated to decrease the number of inhalers used by 2023 by 7,466,621 compared to a scenario without RESPIMAT re-usable, which would result in a reduction of the environmental burden of inhaler use of 4717 tCO(2)e and a decrease in societal cost of €205,888. CONCLUSIONS: Adopting RESPIMAT re-usable would lead to a substantial reduction in CO(2) emissions, leading to savings from a societal perspective. FUNDING: Boehringer Ingelheim. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12325-019-01114-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6860470
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-68604702019-12-03 A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux Ortsäter, Gustaf Borgström, Fredrik Soulard, Stéphane Miltenburger, Carolin Adv Ther Original Research INTRODUCTION: The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies and inclusion of ecological considerations in the decision-making process for purchasing and funding of healthcare technologies. The objective of this study was to perform budget impact analysis of adopting RESPIMAT re-usable in the Nordics and Benelux that considered both the traditional healthcare costs as well as the environmental impact. METHODS: Inhaler costs and environmental impact over 5 years in the Nordics and Benelux in a scenario with RESPIMAT re-usable compared to a scenario without RESPIMAT re-usable were estimated using an budget impact model. RESPIMAT re-usable enables patients to re-use the inhaler device and its availability therefore reduces the number of inhalers and associated wastage. The carbon emissions were derived for each treatment pattern considering the whole life cycle (cradle-to-grave) of the inhaler product. The cost of carbon emissions was estimated using a societal cost per ton of carbon emission. RESULTS: Progressively introducing RESPIMAT re-usable in the Nordics and Benelux was estimated to decrease the number of inhalers used by 2023 by 7,466,621 compared to a scenario without RESPIMAT re-usable, which would result in a reduction of the environmental burden of inhaler use of 4717 tCO(2)e and a decrease in societal cost of €205,888. CONCLUSIONS: Adopting RESPIMAT re-usable would lead to a substantial reduction in CO(2) emissions, leading to savings from a societal perspective. FUNDING: Boehringer Ingelheim. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12325-019-01114-1) contains supplementary material, which is available to authorized users. Springer Healthcare 2019-10-17 2019 /pmc/articles/PMC6860470/ /pubmed/31625130 http://dx.doi.org/10.1007/s12325-019-01114-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Ortsäter, Gustaf
Borgström, Fredrik
Soulard, Stéphane
Miltenburger, Carolin
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
title A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
title_full A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
title_fullStr A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
title_full_unstemmed A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
title_short A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
title_sort budget impact model to estimate the environmental impact of adopting respimat(®) re-usable in the nordics and benelux
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860470/
https://www.ncbi.nlm.nih.gov/pubmed/31625130
http://dx.doi.org/10.1007/s12325-019-01114-1
work_keys_str_mv AT ortsatergustaf abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT borgstromfredrik abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT soulardstephane abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT miltenburgercarolin abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT ortsatergustaf budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT borgstromfredrik budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT soulardstephane budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux
AT miltenburgercarolin budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux